Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Rusfertide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Protagonist & Takeda's ASCO Presentation on Ph 3 VERIFY Study
    Protagonist & Takeda's ASCO Presentation on Ph 3 VERIFY Study

    01 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250531031305/en/Protagonist-and-Takeda-Announce-ASCO-Plenary-Presentation-Highlighting-Full-32-Week-Results-from-Phase-3-VERIFY-Study-of-Rusfertide-Showing-Reductions-in-Phlebotomy-Improved-Hematocrit-Control-in-Polycythemia-Vera

    BUSINESSWIRE
    01 Jun 2025
    Share Share
    Protagonist, Takeda’s Rusfertide Ph 3 VERIFY Study Positive
    Protagonist, Takeda’s Rusfertide Ph 3 VERIFY Study Positive

    03 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250303474433/en

    BUSINESSWIRE
    03 Mar 2025
    Share Share
    Protagonist Hosts Investor Event On PV, Rusfertide In New York
    Protagonist Hosts Investor Event On PV, Rusfertide In New York

    29 Jan 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/protagonist-to-host-investor-event-with-kol-insights-on-polycythemia-v-975919

    ACCESSWIRE
    29 Jan 2025
    Share Share
    Takeda touts 6 pipeline assets with big sales potential
    Takeda touts 6 pipeline assets with big sales potential

    16 Jan 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jpm25-takeda-spotlights-6-later-stage-assets-could-subvert-entyvio-pressures-20b-collective

    FIERCE PHARMA
    16 Jan 2025
    Share Share
    Protagonist Reports Long Term Rusfertide Results At EHA2024 Congress
    Protagonist Reports Long Term Rusfertide Results At EHA2024 Congress

    14 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=877298&lang=en

    ACCESSWIRE
    14 Jun 2024
    Share Share
    Protagonist Presents Rusfertide Phase 2 REVIVE OLE Data At EHA 2024
    Protagonist Presents Rusfertide Phase 2 REVIVE OLE Data At EHA 2024

    14 May 2024

    // ACCESSWIRE

    https://www.accesswire.com/863148/protagonist-therapeutics-announces-oral-presentation-on-long-term-follow-up-of-rusfertide-phase-2-revive-study-open-label-extension-at-the-european-hematology-association-2024-congress

    ACCESSWIRE
    14 May 2024
    Share Share